🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨Why should we study circulating tumor DNA (ctDNA)?🧬 Discover how my research on #ctDNA aims to uncover cancer drivers, enable earlier diagnosis, and pave the way for new treatments 💉💊 ⁦Moffitt Cancer Center⁩ ⁦Moffitt Research⁩ #Womeninresearch #NSCLC #MoffittAmbassadors

🌟 Unlock new possibilities in #LungCancer #Research Submit your abstract by Sept 30 ➡ce.ceconcepts.com/EGFR24 Jill Feldman Zosia Piotrowska @egfrresisters Stephen V Liu, MD Helena Yu Mary Jo Fidler Christine Lovly, MD, PhD, FASCO @CEC_onc #LCSM #EGFR #EGFRSummit

Congratulations to Dr. Julie Brahmer Dr. Julie Brahmer - this year’s Paul A. Bunn Jr. Scientific Award winner for lifetime achievement and we’re ready to celebrate at #WCLC24!

Best block party and lots of dancing through the 70s, 80s, 90s and 2000s at the IASLC 50th anniversary celebration! #WCLC24 Dr. Julie Brahmer Patrick Forde Jarushka Naidoo Susan Combs Scott, MD

First-line treatment for #EGFR NSCLC is more complex, with approvals for osimertinib (FLAURA), osi + chemo (FLAURA2), and amivantamab + lazertinib (MARIPOSA). Dr. Susan Combs Scott, MD at #DCLung24 highlights the space. Will we see a significant OS improvement?

⁦Susan Combs Scott, MD⁩ discussing first line EGFR therapies #Flaura2 #MARIPOSA lots of evolving data #DCLung24 ⁦Stephen V Liu, MD⁩

Excellent debate at #WLC25 by ⁦Susan Combs Scott, MD⁩ and ⁦Balazs Halmos⁩ both deserved a trophy but Dr Scott delivered the knockout!

#WLC25 Susan Combs Scott, MD Johns Hopkins Thoracic Oncology knocked it out of the park⚾️🏟️winning 🥇argument that osimertinib monotherapy is no longer the 2025 standard for 1L EGFR+ NSCLC (highlighting FLAURA2 & MARIPOSA trials) EGFR Resisters #lcsm PER

Dr. Julie Brahmer Susan Combs Scott, MD Very well deserved by my young and worthy challenger! But can someone tell me where i can collect my speaking fee of $20 million???

Had a great time with Susan Combs Scott, MD discussing #HER2 and lunging cancer with Peer Direct!

#TexasLung25 Dr. Xiuning Le MD PhD sets the stage by discussing 1L therapy in #EGFR NSCLC, comparing and contrasting various strategies available to our patients with advanced disease.

Don’t mess with Texas…or Tina. TLC Conference IASLC

Mariam Alexander Eric K. Singhi, MD TLC Conference Stephen V Liu, MD Zosia Piotrowska Joel W. Neal, MD, PhD Susan Combs Scott, MD Susie is a legend and OS for the win indeed- ami/lazer does take some extra effort but unprecedented median OS>4 yrs makes it compelling! Now our patients need a companion bag for the extra meds/creams with it - so by popular demand i re-designed my original hefty ami/lazer

✨EXCLUSIVE✨: Lung cancer experts discuss the evolving use of antibody-drug conjugates in non–small cell lung cancer. Dr. Estela Rodriguez Tarek mekhail Balazs Halmos Susan Combs Scott, MD Dr. Julie Brahmer Corey Langer Benjamin Levy #lcsm #oncology Sign up to watch! onclive.com/view/lung-canc…

Aakash Desai, MD, MPH, FASCO JTO & JTO CRR LungCancerRx 🫁💊 OncoDaily Thanks for sharing this, Aakash Desai, MD, MPH, FASCO! Just yesterday we were talking about this with Susan Combs Scott, MD! Curious, any subgroup analysis on the use of dual checkpoint vs single agent IO or IO + Chemo (as in melanoma, these patients often get dual ICI upfront) Stephen V Liu, MD Allison Betof Warner, MD, PhD?

Join me and a distinguished roster of renowned experts at the D.C. Lung Cancer Conference 2025! This conference will focus on practical, up-to-date strategies for clinicians from all disciplines who care for patients with Lung Cancer. Register today at medstarhealth.org/dclung25

Treatment Algorithm series: mNSCLC w/ actionable mutations in 1L with Susan Combs Scott, MD ✅ EGFR ✅ ALK ✅ ROS1/BRAF/RET/NTRK/MetExon14 Full discussion: ⭐️ oncbrothers.com/nsclc-targeted… ⭐️ “Oncology Brothers” podcast #lcsm #OncTwitter #LungCancer OncUpdates

Treatment Algorithm: This is the algorithm we have use during our discussion w/ Susan Combs Scott, MD for mNSCLC with potential actionable mutation in 1L! #OncTwitter #MedTwitter #lcsm

We asked 5 top lung cancer experts which #ASCO2025 presentations are a must-see—and why. 🎙️ Featuring: Joshua Sabari, MD, Sandip Patel MD FASCO, Susan Combs Scott, MD, Desai, & Qin 👉 Get their picks—sign up for exclusive access! hubs.li/Q03nrrcy0

As my thoughtful colleagues provide advice for #ASCO25 attendees, here’s a list of stupid stuff to avoid (guilty as charged) #fiASCO 1. Wearing cute shoes. Just no. 2. Scheduling meetings in the right time zone-I screw this up and have overlapping meetings at least once a year